NORGINE PARTNERS WITH THE MAKE SENSE CAMPAIGN

Back to media releases
Next media release
07 July 2017

CORPORATE PRESS RELEASE

NORGINE PARTNERS WITH THE MAKE SENSE CAMPAIGN

·        Raising awareness of the role of sentinel lymph node mapping in head and neck cancer

·        Highlighting the importance of nuclear medicine as a critical part of the multi-disciplinary team

 

Amsterdam, The Netherlands. Friday 7 July 2017, 08:00 CET. Norgine B.V. today announced that it is partnering with the Make Sense campaign, which is led by the European Head and Neck Society (EHNS). The collaboration aims to raise awareness of sentinel lymph node biopsy, mapping and identification in head and neck cancer treatment. It also aims to highlight the importance of nuclear medicine as a critical part of the multi-disciplinary team.

This new collaboration will build on the well-established Make Sense campaign, which aims to raise awareness of head and neck cancer across Europe and elsewhere*. All campaign activities are focussed on educating healthcare professionals (HCPs) and members of the general public on disease prevention, including signs and symptoms, which aims to drive earlier presentation, diagnosis and referral. Through this collaboration, there will be an additional focus on educating HCPs about sentinel lymph node mapping in head and neck cancer, to ensure better treatment plans and patient care.

Dr Alastair Benbow, Chief Development and Medical Officer, Norgine, said “As a patient centric company, we are committed to improving the treatment of patients with head and neck cancer. Through this important collaboration we aim to increase awareness of the role that sentinel lymph node mapping can play in identifying tumours in the head and neck, to ensure the most appropriate treatment is chosen.”

“Head and neck cancer is the seventh most common type of cancer in Europe, and its incidence is increasing. Through this partnership we hope to continue to address head and neck cancer unmet needs by improving healthcare professional understanding of the evolving treatment landscape, consequently improving patient outcomes.” said Prof. C. René Leemans, EHNS President.

 

Ends

 

* South Korea and India

 

Notes to Editors:

About Norgine

Norgine is a leading European specialist pharmaceutical company with a direct commercial presence in all major European markets. In 2016, Norgine’s total revenue was EUR 368 million. Norgine employs over 1,000 people across its commercial, development and manufacturing operations and manages all aspects of product development, production, marketing, sale and supply.

Norgine specialises in gastroenterology, hepatology, cancer and supportive care.

 

Norgine is headquartered in the Netherlands. Norgine owns a R&D site in Hengoed, Wales and two manufacturing sites in Hengoed, Wales and Dreux, France.

 

For more information, please visit www.norgine.com

In 2012, Norgine established a complementary business Norgine Ventures, supporting innovative healthcare companies through the provision of debt-like financing in Europe and the US. For more information, please visit www.norgineventures.com.

NORGINE and the sail logo are trademarks of the Norgine group of companies.

 

The European Head and Neck Society (EHNS) and the Make Sense campaign

The EHNS is a multidisciplinary body that brings medical experts together from many disciplines, including head and neck cancer specialists, oral and plastic surgeons, radiation therapists, medical oncologists, imaging specialists and pathologists. The society also brings together other stakeholders, including speech therapists, cancer nurses, psychologists, physiotherapists, dieticians, social workers, basic scientists and patient organisations involved in any aspect of head and neck cancer.

 

The Make Sense campaign is a unique and exciting initiative led by the European Head and Neck Society (EHNS), founded by Prof. Jean Louis Lefebvre and led by EHNS President Prof. C. René Leemans. Through the Campaign, the EHNS aims to raise awareness of head and neck cancer symptoms and subsequently drive earlier presentation, diagnosis and referral, ultimately improving the lives of patients.

 

For more information about the Make Sense campaign, please visit: www.makesensecampaign.eu

 

For more information on the society, please visit: www.ehns.org

Norgine Media Contacts

Isabelle Jouin, T: +44 (0)1895 453643

Charlotte Andrews, T: +44 (0)1895 453607

Follow us @norgine

 

Make Sense Campaign Secretariat

Karley Ura, T: +44 (0)20 3595 2415, M: +44 (0)7525 888 458